A Agresti
- Clinical Biochemistry top 0.5%
- Advanced Glycation End Products research 5
- Immunology top 5%
- Immune Response and Inflammation 10
- Immunotherapy and Immune Responses 6
- Cancer Research top 5%
- NF-κB Signaling Pathways 12
- Molecular Biology top 5%
- RNA Research and Splicing 7
- Genomics and Chromatin Dynamics 6
- DNA Repair Mechanisms 5
- RNA and protein synthesis mechanisms 5
- Neurology top 5%
- Co-authors
- Marco E. BianchiSamuel ZambranoAndrea SpitaleriLuca MollicaGiovanna MuscoFrancesco De MarchisMoreno ZamaiRaffaella Meneveri
- Journals
- Nature Communications (2 papers)iScience (2 papers)International Archives of Allergy and Immunology (2 papers)
- Partner nations
- ItalySpainUnited States
In The Last Decade
A Agresti
48 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Clinical Biochemistry 714
- Immunology 882
- Cancer Research 405
- Molecular Biology 1.6k
- Neurology 174
Countries citing papers authored by A Agresti
This map shows the geographic impact of A Agresti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Agresti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Agresti more than expected).
Fields of papers citing papers by A Agresti
This network shows the impact of papers produced by A Agresti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Agresti. The network helps show where A Agresti may publish in the future.
Co-authorship network
The 25 scholars most cited alongside A Agresti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 4 | |
| 3 | 2021 | 53 | |
| 4 | 2020 | 31 | |
| 5 | 2019 | 4 | |
| 6 | 2019 | 0 | |
| 7 | 2018 | 62 | |
| 8 | 2015 | 10 | |
| 9 | 2009 | 98 | |
| 10 | 2009 | 28 | |
| 11 | Glycyrrhizin Binds to High-Mobility Group Box 1 Protein and Inhibits Its Cytokine Activitiesbreakdown → | 2007 | 490 |
| 12 | 2006 | 164 | |
| 13 | 2003 | 108 | |
| 14 | 2003 | 84 | |
| 15 | 1998 | 57 | |
| 16 | 1996 | 23 | |
| 17 | 1993 | 41 | |
| 18 | 1993 | 24 | |
| 19 | 1993 | 31 | |
| 20 | Use of cephalexin in the oral therapy of deep pyoderma in dogs. | 1990 | 1 |
About A Agresti
A Agresti is a scholar working on Immunology, Cancer Research, Clinical Biochemistry, Molecular Biology and Agronomy and Crop Science, having authored 49 papers that have together received 3.0k indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (12 papers), Immune Response and Inflammation (10 papers), RNA Research and Splicing (7 papers), Immunotherapy and Immune Responses (6 papers), Genomics and Chromatin Dynamics (6 papers), DNA Repair Mechanisms (5 papers), RNA and protein synthesis mechanisms (5 papers) and Advanced Glycation End Products research (5 papers). The work is most often cited by research in Clinical Biochemistry (714 citations), Immunology (882 citations), Cancer Research (405 citations), Molecular Biology (1.6k citations) and Neurology (174 citations). A Agresti has collaborated with scholars based in Italy, Spain and United States. Frequent co-authors include Marco E. Bianchi, Samuel Zambrano, Andrea Spitaleri, Luca Mollica, Giovanna Musco, Francesco De Marchis, Moreno Zamai, Raffaella Meneveri, Enrico Ginelli and Donata Vercelli. Their work appears in journals such as Nature Communications, iScience, International Archives of Allergy and Immunology, Journal of Visualized Experiments and Current Opinion in Genetics & Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.